U.S., Aug. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07791303) titled 'Safety, Tolerability and Pharmacokinetics of Oral Ketamir-2 in Healthy Adult Subjects' on Aug. 19.
Brief Summary: This is a prospective, randomized, double-blind, placebo-controlled study designed to evaluate the safety, tolerability, and pharmacokinetics of oral Ketamir-2 in healthy adult participants. The study includes single ascending dose cohorts and multiple ascending dose cohorts.
Study Start Date: March 20, 2025
Study Type: INTERVENTIONAL
Condition:
Healthy Adult Participants
Intervention:
DRUG: Ketamir-2
Ketamir-2, also referred to as Ketamir hemipamoate, was administered orally as capsules containing 50 mg or 300 mg...